The European Union published its current Good Distribution Practice guidelines on 5 November 2013, under the reference 2013/C 343/01. Thirteen years later, most Canadian Licensed Producers still read GDP as their importer's problem. It isn't.
EU Good Distribution Practice is the rulebook for how medicinal products are stored, moved and documented after they leave the manufacturing site. It legally binds the holder of an EU wholesale distribution authorisation, not the Canadian exporter. Every obligation your importer carries under it, though, converts into a documentation demand pointed straight back at your shipping floor.
That is where consignments get held. You can hold EU-GMP certification, pass a GACP audit and still watch a pallet sit in quarantine because nobody can produce a qualified transport lane or a readable temperature record for the Montreal leg. The gap is rarely the flower. It's the paperwork about the journey.
What EU good distribution practice covers and who it binds
GDP sits in Articles 84 and 85b(3) of Directive 2001/83/EC, the EU code governing medicinal products for human use. The operative text is the Guidelines on Good Distribution Practice of medicinal products for human use, printed in the Official Journal on 5 November 2013 and applicable from the following day. They replaced the 1994 guidance and a March 2013 revision that contained factual errors.
Article 80(g) of the same Directive states the duty plainly: anyone acting as a wholesale distributor complies with GDP. Wholesale distribution requires a wholesale distribution authorisation, usually shortened to WDA. A manufacturing authorisation carries distribution rights for that manufacturer's own products, so an EU site shipping its own output answers to GDP as well.
The scope is wider than most suppliers assume
Wholesale distribution is defined without reference to customs geography. A free zone or a bonded warehouse sits inside the rules, not outside them. Exporting, holding and supplying all count as distribution activities. Brokers who never physically touch a pallet still carry a registration duty in the member state where they operate.
Canada sits outside that authorisation structure completely. No Canadian LP holds a WDA, and Health Canada maintains no GDP equivalent. Good production practices under the Cannabis Regulations govern conditions at your site, not the standard applied to your freight. GDP still reaches you, just contractually, through the importer who holds the authorisation and answers for whatever arrives.
Where a Canadian supplier sits in the GDP chain
Four quality standards stack across an EU-bound cannabis consignment, each handing off to the next. GACP governs cultivation and primary processing. EU-GMP governs manufacturing and packaging. GDP governs everything from the moment finished product leaves the manufacturing site. QP batch release is the final gate, and the Qualified Person signing it is entitled to ask what happened in transit.
Chapter 9 of the guidelines puts transport responsibility on the supplying wholesale distributor. Protect the product against breakage, adulteration and theft. Hold temperature inside acceptable limits. Then demonstrate, afterwards, that nothing exposed the goods to conditions capable of compromising quality or integrity. The mode of transport does not soften the duty, and the planning behind it is expected to be risk-based.
There is no EU temperature limit for cannabis flower
Buyers often ask which range GDP mandates. None. The guidelines require product to be held inside its own stated storage conditions, which means the number comes from your stability data and the specification agreed with the importer, then goes into the technical agreement. A supplier quoting a range it has never tested is arranging its own first excursion.
Incoterms decide who is holding the file
The word "supplying" is doing quiet work in that sentence. Under EXW or FCA, control transfers early and the importer's GDP clock starts at a Canadian dock. Under DAP or DDP, you or your nominated carrier generate the record your importer will later be audited against. Agreeing Incoterms without reading Chapter 9 is how a supplier accepts obligations it never priced.
Small LPs without a dedicated quality function should not be selling DAP into Germany. The transport documentation load is real, and it falls hardest on the party with the fewest people to carry it.
The five GDP evidence files a Canadian exporter should hold
Call it the Canadian Exporter GDP Evidence Pack. Five files, each tied to a chapter of the guidelines, each one an importer's auditor can request without notice.
| Evidence file | What it proves | GDP chapter | Who asks for it |
|---|---|---|---|
| Storage mapping record | Finished-goods areas hold their stated range across seasons | Chapter 3, premises and equipment | Importer QA at supplier qualification |
| Lane and packaging qualification | This configuration holds condition on this route, summer and winter | Chapter 9, transportation | Importer QA, before first shipment |
| Per-consignment temperature data | This batch travelled inside limits, logger read on arrival | Chapter 9, transportation | The Qualified Person, at release |
| Deviation and excursion file | Excursions were detected, assessed against stability data, closed with CAPA | Chapter 1, quality management | Inspectors, during importer audits |
| Technical agreement | Responsibilities are written down and subcontractors qualified | Chapter 7, outsourced activities | Importer QA and competent authority |
None of this requires a WDA to produce. Every file is something a Montreal facility can build with its own procedures, its own data loggers and a forwarder willing to sign a contract. The reason so few Canadian producers hold all five is simple enough: no Canadian regulator has ever asked for them.
Where consignments actually stall
Six failure modes come up again and again, and none of them involve the flower itself.
- Validated packaging mistaken for a qualified lane. A thermal shipper tested on a bench is not evidence about a Montreal to Frankfurt routing in July.
- One configuration used year round. Seasonal configuration is an explicit expectation, and a winter pack sent in August writes its own deviation report.
- Data loggers positioned for convenience rather than worst case, then never downloaded because nobody owns the arrival step.
- No written technical agreement with the freight forwarder or customs broker, leaving responsibilities assumed instead of assigned.
- Excursion data with no stability data behind it. An importer cannot accept a four-hour excursion if you cannot show what the product does at that temperature, which is where water activity control and stability work start paying for themselves.
- Assuming Canadian good production practices map across. They do not, and an auditor fluent in both frameworks finds the seam in about ten minutes.
Rehearse the recall pathway before you need it. Chapter 6 obliges the distributor to trace and retrieve product, which only functions if your batch records reconcile with theirs on the first attempt. Recall readiness is a joint exercise, never a purely Canadian one.
AlphaLeaf is a Health Canada Licensed Producer in Montreal, growing indoor, hand-trimmed flower from refined genetics. We run ISO/IEC 17025 batch testing with full traceability and hold export authorisation under the Cannabis Act, so the storage, transport and deviation records our European import partners rely on are built while the batch moves rather than reconstructed afterwards.
If you're qualifying a Canadian supplier for the European medical channel, ask for those five files before you ask for a price list. Our certifications are published, and our export team will walk your QA lead through a lane qualification on request. Start there. The flower is the easy part.
Frequently Asked Questions
What is EU Good Distribution Practice?
It is the European standard for storing, transporting and documenting medicinal products after they leave the manufacturing site. The guidelines were published as 2013/C 343/01 and sit under Articles 84 and 85b(3) of Directive 2001/83/EC. They cover premises, documentation, outsourced activities, recalls and transport.
Does a Canadian cannabis exporter need GDP certification?
No. GDP obligations attach to holders of an EU wholesale distribution authorisation, and a Canadian Licensed Producer cannot hold one. Your importer holds it instead, then passes the evidence requirements down through supply contracts and supplier audits.
Who is responsible for temperature control on a cannabis shipment to the EU?
Chapter 9 places the duty on the supplying wholesale distributor for each leg. Which company that is depends on the Incoterm you agreed. Under DAP or DDP the Canadian side generates the transit record. Under EXW or FCA the importer picks it up at a Canadian dock.
What is the difference between EU-GMP and EU GDP?
EU-GMP applies to manufacturing, packaging and quality control at the production site. GDP takes over once finished product leaves that site and follows it through storage, transport and delivery. A producer can hold EU-GMP certification and still fail a GDP-driven audit question about transit.
What transport records do European cannabis importers ask for?
Typically a lane and packaging qualification report, continuous temperature data for the specific consignment, and a deviation file showing how any excursion was assessed against stability data. Many also request the technical agreement covering your forwarder.
Does Health Canada require good distribution practice for cannabis exports?
There is no Canadian equivalent. Good production practices under the Cannabis Regulations govern conditions at the licensed site, not the standard applied to freight once it leaves. Canadian exporters build GDP-grade transport evidence voluntarily, because European buyers require it.
